Biopharma companies can help healthcare providers and specialist physicians stay abreast of scientific and medical information. Sej Brar describes what it takes to reshape and transform the strategic relevance of the medical affairs function. Related Practice Life Sciences & Pharma
Organization & Performance Published Articles Working From Home after COVID-19: businesses need to allow flexibility, or they will lose… May 4, 2020 As businesses consider the likely shape of recovery from lockdown, we have researched the impact of the current enforced experience of working from home…
Life Sciences & Pharma Executive Insights A Lasting Legacy: Building a Successful Business From Established Brands November 21, 2019 Legacy brands can form the foundation of a successful business, particularly for specialized players with the appropriate organizational structure and the…
Life Sciences & Pharma Presentations European Disease Progression Monitor: Edition 5 April 28, 2020 Each week we will update our staff and clients with metrics to track disease progression
Organization & Performance Presentations Working from Home after COVID July 21, 2020 COVID-19 is shaping a ‘new normal’ in working from home (WFH) that is expected to persist in the long term. L.E.K. researched how working patterns have…
MedTech Published Articles L.E.K.’s Take on China Medtech: Optimistic Macro View, Short-Term Hit Hard March 17, 2020 Despite the COVID-19 lockdown, Stephen Sunderland foresees limited disruption
Paper & Packaging Executive Insights How Can Corporates and Private Equity Firms Win in Healthcare Packaging? January 24, 2020 For both corporates and private investors looking to enter a lucrative market with long-term potential, healthcare packaging holds significant promise.
